Results for tag: "Emphysema"

Emphysema is a chronic lung disease that is part of a group of conditions known as chronic obstructive pulmonary disease (COPD). It is characterized by the destruction of the alveoli, the tiny air sacs in the lungs, which leads to difficulty breathing. The primary cause of emphysema is smoking, but it can also be caused by air pollution, genetics, and other environmental factors. Treatment for emphysema includes lifestyle changes, such as quitting smoking, as well as medications and oxygen therapy. In some cases, surgery may be necessary. The emphysema market is a subset of the larger pulmonary medicine market. It is composed of pharmaceutical companies, medical device companies, and other healthcare providers that offer products and services related to the diagnosis and treatment of emphysema. Companies in this market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, and Merck. Additionally, there are a number of smaller companies that specialize in the development of new treatments for emphysema. Show Less Read more